HIV inhibitors targeted at the reverse transcriptase.

作者: ERIK DE CLERCQ

DOI: 10.1089/AID.1992.8.119

关键词:

摘要: HIV inhibitors targeted at the virus-associated reverse transcriptase (RT) can be divided into two groups, depending on whether they are substrate or nonsubstrate binding site. To first group belong 2′,3′-dideoxynucleosides (i.e., DDC, DDI), 3′-azido-2′,3′-dideoxynucleosides AZT), 3′-fluoro-2′,3′dideoxynucleosides FLT), 2′,3′-didehydro-2′,3′-dideoxynucleosides D4C, D4T) and carbocyclic derivatives thereof carbovir), 2′-fluoro-ara-2′,3′-dideoxynucleosides, 1,3-dioxolane 2′,3′-dideoxyl-3′-thiacytidine), oxetanocin analogues cyclobut-G) 9-(2-phosphonylmethoxyethyl)adenine (PMEA) 9-(3-fluoro-2-phosphonylmethoxypropyl)adenine (FPMPA) derivatives. These compounds need to phosphorylated intracellularly their triphosphate forms before act as competitive alternate substrates (chain terminators) of RT. The second includes tetrahydro-imidazo[4,5,l-jk][1,...

参考文章(103)
Daniel W. Norbeck, Stephen Spanton, Samuel Broder, Hiroaki Mitsuya, (±)-Dioxolane-T ((±)-1-[(2β,4β)-2-(hydroxymethyl)-4-dioxolanyl]thymine): a new 2',3'-dideoxynucleoside prototype with in vitro activity against HIV Tetrahedron Letters. ,vol. 30, pp. 6263- 6266 ,(1989) , 10.1016/S0040-4039(01)93868-7
Jan Balzarini, Rudi Pauwels, Piet Herdewijn, Erik De Clercq, David A. Cooney, Gil-Jong Kang, Maha Dalal, David G. Johns, Samuel Broder, Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine. Biochemical and Biophysical Research Communications. ,vol. 140, pp. 735- 742 ,(1986) , 10.1016/0006-291X(86)90793-X
Ronald Rooke, Michel Tremblay, Hugo Soudeyns, Lucie DeStephano, Xiao-Jian Yao, Mary Fanning, Julio S.G. Montaner, Michael OʼShaughnessy, Karen Gelmon, Chris Tsoukas, John Gill, John Ruedy, Mark A. Wainberg, Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group. AIDS. ,vol. 3, pp. 411- 416 ,(1989) , 10.1097/00002030-198907000-00001
Erik De Clercq, Arthur Van Aerschot, Piet Herdewijn, Masanori Baba, Rudi Pauwels, Jan Balzarini, Anti-Hiv-1 Activity of 2′,3′-Dideoxinucleoside Analogues : Structure-Activity Relationship Nucleosides, Nucleotides & Nucleic Acids. ,vol. 8, pp. 659- 671 ,(1989) , 10.1080/07328318908054206
Jai Tung Huang, Ling Ching Chen, Liben Wang, Moon Hwan Kim, James A. Warshaw, Donald Armstrong, Qing Yu Zhu, Ting Chao Chou, Kyoichi A. Watanabe, Fluorinated sugar analogues of potential anti-HIV-1 nucleosides. Journal of Medicinal Chemistry. ,vol. 34, pp. 1640- 1646 ,(1991) , 10.1021/JM00109A017
Donna M. Huryn, Barbara C. Sluboski, Steve Y. Tam, Louis J. Todaro, Manfred Weigele, Synthesis of iso-ddA, member of a novel class of anti-HIV agents Tetrahedron Letters. ,vol. 30, pp. 6259- 6262 ,(1989) , 10.1016/S0040-4039(01)93867-5
Erik De Clercq, Antonin Holý, Ivan Rosenberg, Takashi Sakuma, Jan Balzarini, Parbhat C. Maudgal, A novel selective broad-spectrum anti-DNA virus agent. Nature. ,vol. 323, pp. 464- 467 ,(1986) , 10.1038/323464A0
Barbara H. Arnold, Deborah L. Cannon, Bogan Doboszewski, Vishweshwar B. Bhadti, Ziping Gu, Chung K. Chu, Raymond F. Schinazi, Comparative activity of 2′,3′-saturated and unsaturated pyrimidine and purine nucleosides against human immunodeficiency virus type 1 in peripheral blood mononuclear cells Biochemical Pharmacology. ,vol. 37, pp. 3543- 3548 ,(1988) , 10.1016/0006-2952(88)90383-8
Erik De Clercq, New acquisitions in the development of anti-HIV agents. Antiviral Research. ,vol. 12, pp. 1- 19 ,(1989) , 10.1016/0166-3542(89)90064-8
S. Hayashi, S. Phadtare, J. Zemlicka, M. Matsukura, H. Mitsuya, S. Broder, Adenallene and cytallene: Acyclic nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro Proceedings of the National Academy of Sciences of the United States of America. ,vol. 85, pp. 6127- 6131 ,(1988) , 10.1073/PNAS.85.16.6127